Cigna Corp (NYSE:CI) Position Cut by Rampart Investment Management Company LLC

Share on StockTwits

Rampart Investment Management Company LLC trimmed its stake in Cigna Corp (NYSE:CI) by 4.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 4,409 shares of the health services provider’s stock after selling 209 shares during the quarter. Rampart Investment Management Company LLC’s holdings in Cigna were worth $695,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of CI. Redhawk Wealth Advisors Inc. purchased a new position in Cigna in the 2nd quarter worth about $28,000. Virtus ETF Advisers LLC acquired a new stake in Cigna during the 2nd quarter worth about $30,000. TRUE Private Wealth Advisors acquired a new stake in Cigna during the 2nd quarter worth about $40,000. Prime Capital Investment Advisors LLC boosted its position in Cigna by 32.5% during the 2nd quarter. Prime Capital Investment Advisors LLC now owns 257 shares of the health services provider’s stock worth $40,000 after acquiring an additional 63 shares during the period. Finally, Glassman Wealth Services boosted its position in Cigna by 33.3% during the 2nd quarter. Glassman Wealth Services now owns 320 shares of the health services provider’s stock worth $50,000 after acquiring an additional 80 shares during the period. Institutional investors own 87.40% of the company’s stock.

A number of equities research analysts have commented on the company. Citigroup restated a “buy” rating on shares of Cigna in a research report on Wednesday, August 21st. Stephens set a $225.00 price objective on Cigna and gave the stock a “buy” rating in a research report on Friday, August 23rd. Raymond James lifted their price target on Cigna from $185.00 to $190.00 and gave the company an “outperform” rating in a report on Friday, August 2nd. Sanford C. Bernstein upgraded Cigna from a “market perform” rating to an “outperform” rating and set a $205.00 target price for the company in a report on Tuesday, August 6th. Finally, Oppenheimer set a $254.00 target price on Cigna and gave the stock a “buy” rating in a report on Tuesday, September 10th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $213.33.

In related news, CEO David Cordani bought 32,509 shares of the business’s stock in a transaction on Monday, September 9th. The stock was acquired at an average price of $155.17 per share, with a total value of $5,044,421.53. Corporate insiders own 0.80% of the company’s stock.

NYSE CI traded up $4.90 during trading hours on Thursday, hitting $165.34. 1,186,805 shares of the company traded hands, compared to its average volume of 2,063,453. The business’s 50-day moving average is $160.16 and its 200-day moving average is $160.92. Cigna Corp has a twelve month low of $141.95 and a twelve month high of $226.60. The company has a debt-to-equity ratio of 0.84, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market capitalization of $60.58 billion, a price-to-earnings ratio of 11.63, a P/E/G ratio of 0.84 and a beta of 0.73.

Cigna (NYSE:CI) last issued its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 EPS for the quarter, beating the consensus estimate of $3.74 by $0.56. The firm had revenue of $34.38 billion during the quarter, compared to analysts’ expectations of $33.27 billion. Cigna had a return on equity of 13.24% and a net margin of 3.60%. The business’s quarterly revenue was up 198.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.89 earnings per share. Analysts predict that Cigna Corp will post 16.77 EPS for the current year.

About Cigna

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Story: How to calculate the intrinsic value of a stock

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.